Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Advances in Cancer Immunotherapy with a Focus on FDA-Approved Vaccines and Neoantigen-Based Vaccines
Anna Hargrave, Abu Salim Mustafa, Asma Hanif, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1633-1633
Open Access | Times Cited: 23

Showing 23 citing articles:

Glioblastoma Vaccines as Promising Immune-Therapeutics: Challenges and Current Status
Asmae Squalli Houssaini, Salma Lamrabet, Jean Paul Nshizirungu, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 655-655
Open Access | Times Cited: 5
Immunotherapy in Recurrent Ovarian Cancer
Keyao Chen, Jingjing Wang, Meng Yang, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 168-168
Open Access
Vaccine-Based Immunotherapy for Oropharyngeal and Nasopharyngeal Cancers
Daria Maria Filippini, Elisabetta Broseghini, Carlotta Liberale, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1170-1170
Open Access
The paths toward immunotherapy of esophageal cancer: An overview of clinical trials
Azfar Jamal, Allolo D Aldreiwish, Saeed Banawas, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114261-114261
Closed Access
Immunogenicity and Safety Profile of Two Adjuvanted-PD-L1-Based Vaccine Candidates in Mice, Rats, Rabbits, and Cynomolgus Monkeys
Camila Canaan-Haden-Ayala, J. Sánchez-Ramírez, Rafael Martínez-Castillo, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 296-296
Open Access
Pediatric gliomas immunity challenges and immunotherapy advances
Eleni‐Kyriaki Vetsika, Maria A. Katsianou, Panagiotis Sarantis, et al.
Cancer Letters (2025), pp. 217640-217640
Closed Access
Advances in Cancer Vaccines: From Traditional Platforms to Nanotechnology Innovations
Nanasaheb D. Thorat
(2025), pp. 1-50
Closed Access
Are we getting closer to a successful neoantigen cancer vaccine?
Karen Manoutcharian, Goar Gevorkian
Molecular Aspects of Medicine (2024) Vol. 96, pp. 101254-101254
Closed Access | Times Cited: 4
Current Progress in Vaccines against Merkel Cell Carcinoma: A Narrative Review and Update
Thilo Gambichler, David Schrama, Riina Käpynen, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 533-533
Open Access | Times Cited: 4
Emerging potential of immunopeptidomics by mass spectrometry in cancer immunotherapy
Yuriko Minegishi, Yoshimi Haga, Koji Ueda
Cancer Science (2024) Vol. 115, Iss. 4, pp. 1048-1059
Open Access | Times Cited: 3
Targeting metabolic pathways to counter cancer immunotherapy resistance
Yuki Agarwala, Timothy Brauns, Ann E. Sluder, et al.
Trends in Immunology (2024) Vol. 45, Iss. 7, pp. 486-494
Closed Access | Times Cited: 3
Advancements in Immunotherapy for Breast Cancer: Mechanisms, Efficacy, and Future Directions
Archita Rai, Swati G Deshpande, Ashish Vaidya, et al.
Cureus (2024)
Open Access | Times Cited: 3
Vaccine-based therapeutic interventions in lung cancer management: A recent perspective
Dhruv Gupta, Daksh Sanjay Gupta, Nosheen Kamruddin Abjani, et al.
Medical Oncology (2024) Vol. 41, Iss. 11
Closed Access | Times Cited: 2
Personalized nanovaccines for treating solid cancer metastases
Feng Tang, Jia Hu, Jirui Wen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Fabrication and functional validation of a hybrid biomimetic nanovaccine (HBNV) against Kit-mutant melanoma
Kishwor Poudel, Zhenyu Ji, Ching-Ni Jenny Njauw, et al.
Bioactive Materials (2024) Vol. 46, pp. 347-364
Closed Access | Times Cited: 1
La thérapie cellulaire dans tous ses états
Aurore Dougé, Christophe Caux, Jacques‐Olivier Bay
Bulletin du Cancer (2024) Vol. 111, Iss. 2, pp. 213-221
Closed Access
Therapeutic advantage of combinatorial CAR T cell and chemo-therapies
Meghan B Ward, Amber B. Jones, Giedre Krenciute
Pharmacological Reviews (2024) Vol. 77, Iss. 1, pp. 100011-100011
Open Access
Comparison of Traditional Treatments and Therapeutic Vaccines for Breast Cancer
Aizhen Zhou
Highlights in Science Engineering and Technology (2024) Vol. 102, pp. 407-411
Closed Access
Polymer/Lipid-Based Nanocomplexes in Cancer Immunotherapy
Sarjana Raikwar, Nikhar Vishwakarma, Shivangi Sharma, et al.
(2024), pp. 279-300
Closed Access
Cellules CAR-T et tumeurs solides : où en sommes-nous en France ?
Aurore Dougé, Emmanuel Donnadieu, Jacques‐Olivier Bay
Bulletin de l Académie Nationale de Médecine (2024) Vol. 208, Iss. 8, pp. 1045-1057
Closed Access
Humanized Mouse Models for Immuno-Oncology Research: A Review and Implications in Lung Cancer Research
Cheol‐Kyu Park, Maryam Khalil, Nhu‐An Pham, et al.
JTO Clinical and Research Reports (2024) Vol. 6, Iss. 3, pp. 100781-100781
Open Access
Cancer vaccines: an update on recent achievements and prospects for cancer therapy
Arezki Chekaoui, Mariangela Garofalo, Beata Gad, et al.
Clinical and Experimental Medicine (2024) Vol. 25, Iss. 1
Open Access
Biotherapeutics: General Introduction
Hugo Cerecetto, Victoria Calzada, Juan Pablo Tosar
Topics in medicinal chemistry (2024)
Closed Access
Page 1

Scroll to top